The Swiss government met with executives of Roche Holding AG and Novartis AG to discuss the pharmaceutical industry’s situation in light of US tariffs.

Switzerland’s government has reached out to local drugmakers Roche Holding AG and Novartis AG to discuss the tariff situation ...

Swiss drugmaker Roche Holding plans to investigate whether an experimental medicine can delay or prevent Alzheimer's disease symptoms, it said on Sunday, as a part of the company's growing development ...

Roche Holding AG said on Tuesday it has paused shipments of muscular disorder gene therapy Elevidys in some countries outside the U.S., echoing a similar decision by U.S. partner Sarepta Therapeutics ...

The clean-up bill for Swiss pharma giant Roche's former Co Clare manufacturing site now totals €150.5m in what the company describes as "one of the largest remediation projects of its type in Europe".

Already USFDA-approved, under-the-skin jab can be administered in just seven minutes to the patient. This is dramatic cut ...

The Swiss drugmaker discussed the option of selling drugs directly to patients with U.S. officials following Trump administration calls for the industry to cut prices.

Mr. Roche believes them because he thinks he knows who hired Mr. Ager-Hanssen: Mr. Williams, the British entrepreneur who was the target of Roche Freedman’s biggest pump-and-dump lawsuit.

Roche had bid $91 a share in what it said was its best and final offer. But it would eventually relent and win by bidding $114.50 a share, almost $10 more than its rival, at the end of the day.